Publication: PubMed: 34791404

PubMed ID: 34791404

Citation: Cunningham F, Allen JE, Allen J, et al. Ensembl 2022. Nucleic Acids Res. 2022;50(D1):D988-D995. doi:10.1093/nar/gkab1049

Funding: Wellcome Trust [WT108749/Z/15/Z]; National Human Genome Research Institute of the National Institutes of Health [U41HG007823, 2U41HG007234, U41HG010972, 2U24HG007497-05]; Biotechnology and Biological Sciences Research Council [BB/N019563/1, BB/M011615/1, BB/S020152/1, BB/P016855/1, BB/S02011X/1, BB/P024602/1]; Open Targets, Wellcome Trust [WT104947/Z/14/Z, WT200990/Z/16/Z, WT201535/Z/16/Z, WT108749/Z/15/A, WT212925/Z/18/Z, WT218328/B/19/Z]; British Council [414710385]; ELIXIR: the research infrastructure for life-science data, and the European Molecular Biology Laboratory; European Union's Horizon 2020 research and innovation programme [733161 (MultipleMS), 731060 (INFRAVEC2), 825575 (EJP RD), 817923 (AQUA-FAANG), 817998 (GENESWitCH), 815668 (BovReg)]; Save the Tasmanian Devil Program. Funding for open access charge: Wellcome [WT108749/Z/15/Z].